Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bristol Myers Squibb’s Opdivo shows benefit in oesophageal cancers

pharmatimesSeptember 23, 2020

Tag: Bristol Myers Squibb , Opdivo , CheckMate-577 , cancer

PharmaSources Customer Service